Regentatlantic Capital LLC Seagen Inc. Transaction History

Regentatlantic Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$108.81 - $179.33 $147,655 - $243,350	1,357 New	1,357 $240,000
Q1 2022 May 02, 2022	SELL	$119.61 - $157.85 $164,224 - $216,728	-1,373 Closed	0 $0
Q4 2021 Jan 27, 2022	SELL	$142.57 - $190.86 $4,419 - $5,916	-31 Reduced 2.21%	1,373 $212,000
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $116,666 - $139,082	-819 Reduced 36.84%	1,404 $238,000
Q2 2021 Aug 12, 2021	BUY	$135.08 - $161.1 $76,590 - $91,343	567 Added 34.24%	2,223 $351,000
Q1 2021 Apr 29, 2021	BUY	$137.51 - $190.8 $227,716 - $315,964	1,656 New	1,656 $230,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Regentatlantic Capital LLC with notifications on news.